VANECK BIONIC ENGINEERING UCITS ETF - USD |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.25 USD | +0.14% |
|
+0.85% | +1.66% |
| Current month | -4.56% | ||
| 1 month | -1.77% |
Investment objective
VanEck?s Bionic Engineering ETF tracks the performance of the portfolio of innovative companies delivering medical, dental or vision-related implants, bioprinting, prosthesis, or preservation of organs and tissue.
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 323.8 AUD | +0.95% | +0.24% | +8.42% | -.--% | ||
| 258.3 CHF | +0.51% | +1.82% | -6.01% | -.--% | ||
| 139.4 CHF | +0.92% | +2.96% | +2.58% | -.--% | ||
| 337.8 DKK | +3.43% | +5.57% | +14.05% | -.--% | ||
| 79.74 USD | +0.62% | +0.33% | -3.20% | -.--% | ||
| 31.7 EUR | +0.60% | +0.41% | +1.15% | -.--% | ||
| 1,29,900 KRW | -0.08% | -2.62% | -0.84% | -.--% | ||
| 1.69 HKD | +0.60% | +5.62% | -28.09% | -.--% | ||
| 6.27 HKD | +6.27% | +16.11% | -25.53% | -.--% | ||
| 12.44 USD | +1.63% | -0.80% | -17.67% | -.--% | ||
More news
In partnership with
| Date | Price | Change |
|---|---|---|
| 26/24/26 | 21.25 | +0.14% |
| 25/24/25 | 21.22 | -1.83% |
| 24/24/24 | 21.61 | +0.52% |
| 23/24/23 | 21.5 | +1.84% |
| 22/24/22 | 21.11 | +0.21% |
Other stock markets
Delayed Quote London S.E.
Last update April 26, 2024 at 09:05 pm IST
More quotesDescription
| IE0005TF96I9 | |
|---|---|
| Total Expense Ratio | 0.55% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | MVIS Global Bionic Healthcare ESG Index (NTR) - USD |
Features and characteristics
| Jurisdiction | |
| Replication Method | |
| Replication Model | |
| Date of creation |
02/12/2022
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 28/03/2024 )
| AuM (EUR) | 6 M€ |
|---|---|
| AuM 1M | 6 M€ |
| AuM 3 months | 5 M€ |
| AuM 6 months | 5 M€ |
| AuM 12 months | 5 M€ |
- Stock Market
- ETF
- ETF
